A Study of Macupatide (LY3532226) and Eloralintide (LY3841136)
Phase 2
200
about 1.6 years
18–75
22 sites in AZ, GA, NJ +5
What this study is about
Researchers are testing macupatide and eloralintide, alone or in combination, to see if they help people with obesity or overweight who also have type 2 diabetes lose weight. The trial will last about 48 weeks.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Eloralintide
- 2.Take Eloralintide Placebo
- 3.Take Macupatide
- +1 more
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Primary: Percent Change from Baseline in Body Weight
Secondary: Change from Baseline in Body Mass Index (BMI), Change from Baseline in Fasting Glucose, Change from Baseline in Hemoglobin A1c (HbA1c)
Endocrinology